1. |
Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol, 2014, 13(8): 834-843.
|
2. |
Gutmann DH, Ferner RE, Listernick RH, et al. Neurofibromatosis type 1. Nat Rev Dis Primers, 2017, 3: 17004. doi: 10.1038/nrdp.2017.4.
|
3. |
Hsu CK, Denadai R, Chang CS, et al. The number of surgical interventions and specialists involved in the management of patients with neurofibromatosis type Ⅰ: A 25-year analysis. J Pers Med, 2022, 12(4): 558. doi: 10.3390/jpm12040558.
|
4. |
朱倍瑶, 顾熠辉, 王薇, 等. 丛状神经纤维瘤的手术原则及策略. 中华整形外科杂志, 2023, 39(11): 1244-1250.
|
5. |
Fisher MJ, Blakeley JO, Weiss BD, et al. Management of neurofibromatosis type 1-associated plexiform neurofibromas. Neuro Oncol, 2022, 24(11): 1827-1844.
|
6. |
Tucker T, Friedman JM, Friedrich RE, et al. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas. J Med Genet, 2009, 46(2): 81-85.
|
7. |
张儒焱, 陈勇, 李彦豪, 等. 头面部巨大神经纤维瘤病的动脉造影表现和术前栓塞的意义. 中华放射学杂志, 2010, 44(7): 772-773.
|
8. |
Singhal D, Chen YC, Fanzio PM, et al. Role of free flaps in the management of craniofacial neurofibromatosis: soft tissue coverage and attempted facial reanimation. J Oral Maxillofac Surg, 2012, 70(12): 2916-2922.
|
9. |
Latham K, Buchanan EP, Suver D, et al. Neurofibromatosis of the head and neck: classification and surgical management. Plast Reconstr Surg, 2015, 135(3): 845-855.
|
10. |
王薇, 顾熠辉, 朱倍瑶, 等. 121例头颈部丛状神经纤维瘤手术治疗患者的回顾性研究. 中华整形外科杂志, 2024, 40(2): 169-178.
|
11. |
Nguyen R, Ibrahim C, Friedrich RE, et al. Growth behavior of plexiform neurofibromas after surgery. Genet Med, 2013, 15(9): 691-697.
|
12. |
中国Ⅰ型神经纤维瘤病多中心治疗协作组, 全国整形外科多中心研究平台. Ⅰ型神经纤维瘤病临床诊疗专家共识 (2021版). 中国修复重建外科杂志, 2021, 35(11): 1384-1395.
|
13. |
Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet, 2007, 44(2): 81-88.
|
14. |
Salamon J, Mautner VF, Adam G, et al. Multimodal imaging in neurofibromatosis type 1-associated nerve sheath tumors. Rofo, 2015, 187(12): 1084-1092.
|
15. |
Mautner VF, Hartmann M, Kluwe L, et al. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology, 2006, 48(3): 160-165.
|
16. |
Hu X, Bogari M, Tan A, et al. Initial exploration on temporal branch of facial nerve function preservation in plexiform neurofibroma resection. J Craniofac Surg, 2016, 27(6): 1589-1592.
|
17. |
Edizer DT, Hajizade Y, Karaman E, et al. Intraparotid facial nerve neurofibroma in neurofibromatosis type 1. J Craniofac Surg, 2011, 22(3): 1118-1119.
|
18. |
Hivelin M, Wolkenstein P, Lepage C, et al. Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patients. Plast Reconstr Surg, 2010, 125(4): 1197-1207.
|
19. |
Ma N, Li Y, Yang Z, et al. Expansion technique for reconstruction of craniofacial defect after plexiform neurofibroma excision. J Craniofac Surg, 2023, 34(5): 1507-1510.
|
20. |
张剑, 张金明, 葛鋆, 等. 1型神经纤维瘤病的整形外科治疗决策. 中华整形外科杂志, 2021, 37(8): 840-846.
|
21. |
Nguyen R, Dombi E, Widemann BC, et al. Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis, 2012, 7: 75. doi: 10.1186/1750-1172-7-75.
|
22. |
Tung TC, Chen YR, Chen KT, et al. Massive intratumor hemorrhage in facial plexiform neurofibroma. Head Neck, 1997, 19(2): 158-162.
|
23. |
Gao Q, Qu S, Ma N, et al. Risk factors for intraoperative hemorrhage of type Ⅰ neurofibromatosis. BMC Surg, 2023, 23(1): 157. doi: 10.1186/s12893-023-02067-7.
|
24. |
Theos A, Korf BR, American College of Physicians, et al. Pathophysiology of neurofibromatosis type 1. Ann Intern Med, 2006, 144(11): 842-849.
|
25. |
Kosaka M, Miyanohara T, Mochizuki Y, et al. A rare case of a facial-nerve neurofibroma in the parotid gland. Br J Plast Surg, 2002, 55(8): 689-691.
|
26. |
Fadda MT, Verdino G, Mustazza MC, et al. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1. Int J Pediatr Otorhinolaryngol, 2008, 72(5): 553-557.
|
27. |
Ball JR, Biggs MT. Operative steps in management of benign nerve sheath tumors. Neurosurg Focus, 2007, 22(6): E7. doi: 10.3171/foc.2007.22.6.8.
|
28. |
Wang WN, Koguchi-Yoshioka H, Nimura K, et al. Distinct transcriptional profiles in the different phenotypes of neurofibroma from the same subject with neurofibromatosis 1. J Invest Dermatol, 2024, 144(1): 133-141.
|
29. |
Well L, Salamon J, Kaul MG, et al. Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging. Neuro Oncol, 2019, 21(4): 508-516.
|
30. |
Nguyen R, Kluwe L, Fuensterer C, et al. Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr, 2011, 159(4): 652-655.
|
31. |
Guo YX, Wang HX, Wang SS, et al. Treatment with selumetinib for Café-au-Lait macules and plexiform neurofibroma in pediatric patients with neurofibromatosis type 1. JAMA Dermatol, 2024, 160(3): 366-368.
|